Team siliconindia

• Healthium Medtech partners with US based Tisgenx to bring bovine pericardial tissue patches to India.
• The exclusive deal strengthens Healthium’s cardiac care portfolio.
• The partnership focuses on making high quality cardiac surgery tools accessible to Indian surgeons.

Bengaluru based Healthium Medtech has announced an exclusive partnership with US firm Tisgenx, Inc., a global leader in manufacturing bovine pericardial tissue patches used in complex heart surgeries. This strategic tie-up gives Healthium exclusive rights to distribute Tisgenx’s products across India, further strengthening its footprint in the cardiac care segment.

These high performance tissue patches are essential for valve repair, vessel reconstruction, and other cardiovascular and soft tissue procedures. Indian surgeons will now have direct access to these internationally trusted solutions through Healthium’s wide medical distribution network.

 Anish Bafna, CEO & MD of Healthium, said the collaboration underlines their mission to deliver specialty driven and innovative medical tools tailored for Indian needs. “Bringing Tisgenx’s premium-quality tissue patches to India is another step in our journey to support surgeons with reliable, advanced solutions”, he added.

Also Read: Fredun Pharma Launches Plant Based Pet Food 'Snacky Jain' for Pet Health

Kris Kupumbati, CEO & President of Tisgenx, highlighted the importance of India as a rapidly growing healthcare market. He expressed confidence in Healthium’s reach and ability to bring real clinical impact. “This partnership helps us bring world-class innovation to Indian cardiac care and aligns with our shared vision of delivering surgeon-centric and patient-first solutions”, he said.

The deal aligns with Healthium’s strategy to expand in high growth therapeutic areas and make cutting-edge healthcare products more accessible across the country.